Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 35.44 Million CNY | -67.42% |
| 2022 | 108.79 Million CNY | 25.53% |
| 2021 | 86.66 Million CNY | 194.54% |
| 2020 | 29.42 Million CNY | 1.62% |
| 2019 | 28.95 Million CNY | 16.89% |
| 2018 | 24.77 Million CNY | 11695.37% |
| 2017 | 210 Thousand CNY | -99.93% |
| 2016 | 299.86 Million CNY | 0.22% |
| 2015 | 299.19 Million CNY | 0.21% |
| 2014 | 298.57 Million CNY | 0.2% |
| 2013 | 297.98 Million CNY | -5.11% |
| 2012 | 314.04 Million CNY | 0.0% |
| 2011 | - CNY | -100.0% |
| 2010 | 30 Million CNY | 50.0% |
| 2009 | 20 Million CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | -100.0% |
| 2006 | 10.76 Million CNY | 18.01% |
| 2005 | 9.12 Million CNY | 0.0% |
| 2004 | - CNY | 0.0% |
| 2003 | - CNY | -100.0% |
| 2002 | 20 Million CNY | 0.0% |
| 2001 | - CNY | 0.0% |
| 2000 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 48.08 Million CNY | 35.67% |
| 2024 Q2 | 49.16 Million CNY | 2.26% |
| 2024 Q3 | 51.42 Million CNY | 4.58% |
| 2023 FY | 35.44 Million CNY | -67.42% |
| 2023 Q3 | 126.62 Million CNY | 7.32% |
| 2023 Q4 | 35.44 Million CNY | -72.01% |
| 2023 Q1 | 103.6 Million CNY | -4.77% |
| 2023 Q2 | 117.99 Million CNY | 13.88% |
| 2022 Q3 | 110.15 Million CNY | 4.68% |
| 2022 Q4 | 108.79 Million CNY | -1.24% |
| 2022 FY | 108.79 Million CNY | 25.53% |
| 2022 Q1 | 87.49 Million CNY | 0.96% |
| 2022 Q2 | 105.23 Million CNY | 20.27% |
| 2021 Q2 | 115.2 Million CNY | 3.68% |
| 2021 Q1 | 111.11 Million CNY | 277.63% |
| 2021 FY | 86.66 Million CNY | 194.54% |
| 2021 Q4 | 86.66 Million CNY | -22.35% |
| 2021 Q3 | 111.6 Million CNY | -3.12% |
| 2020 Q1 | 28.55 Million CNY | -1.38% |
| 2020 FY | 29.42 Million CNY | 1.62% |
| 2020 Q2 | 28.68 Million CNY | 0.46% |
| 2020 Q4 | 29.42 Million CNY | 4.18% |
| 2020 Q3 | 28.24 Million CNY | -1.54% |
| 2019 Q1 | 25.1 Million CNY | 1.36% |
| 2019 Q3 | 25.5 Million CNY | -0.09% |
| 2019 Q4 | 28.95 Million CNY | 13.52% |
| 2019 FY | 28.95 Million CNY | 16.89% |
| 2019 Q2 | 25.52 Million CNY | 1.68% |
| 2018 Q4 | 24.77 Million CNY | 11695.37% |
| 2018 Q3 | 210 Thousand CNY | -99.06% |
| 2018 Q2 | 22.38 Million CNY | 1.06% |
| 2018 Q1 | 22.14 Million CNY | 10445.97% |
| 2018 FY | 24.77 Million CNY | 11695.37% |
| 2017 Q4 | 210 Thousand CNY | -99.16% |
| 2017 Q2 | 24.7 Million CNY | 0.81% |
| 2017 Q1 | 24.5 Million CNY | -91.83% |
| 2017 FY | 210 Thousand CNY | -99.93% |
| 2017 Q3 | 25.06 Million CNY | 1.43% |
| 2016 Q4 | 299.86 Million CNY | 0.06% |
| 2016 Q3 | 299.69 Million CNY | 0.06% |
| 2016 FY | 299.86 Million CNY | 0.22% |
| 2016 Q2 | 299.52 Million CNY | 0.06% |
| 2016 Q1 | 299.35 Million CNY | 0.05% |
| 2015 Q1 | 298.72 Million CNY | 0.05% |
| 2015 FY | 299.19 Million CNY | 0.21% |
| 2015 Q2 | 298.86 Million CNY | 0.05% |
| 2015 Q4 | 299.19 Million CNY | 0.05% |
| 2015 Q3 | 299.04 Million CNY | 0.06% |
| 2014 Q2 | 298.31 Million CNY | 0.05% |
| 2014 FY | 298.57 Million CNY | 0.2% |
| 2014 Q1 | 298.16 Million CNY | 0.06% |
| 2014 Q4 | 298.57 Million CNY | 0.03% |
| 2014 Q3 | 298.46 Million CNY | 0.05% |
| 2013 Q1 | 314.17 Million CNY | 0.04% |
| 2013 Q2 | 306.35 Million CNY | -2.49% |
| 2013 Q3 | 306.49 Million CNY | 0.05% |
| 2013 FY | 297.98 Million CNY | -5.11% |
| 2013 Q4 | 297.98 Million CNY | -2.78% |
| 2012 FY | 314.04 Million CNY | 0.0% |
| 2012 Q3 | 314.94 Million CNY | 2.99% |
| 2012 Q2 | 305.81 Million CNY | 2.97% |
| 2012 Q1 | 297 Million CNY | 0.0% |
| 2012 Q4 | 314.04 Million CNY | -0.29% |
| 2011 FY | - CNY | -100.0% |
| 2011 Q4 | - CNY | -100.0% |
| 2011 Q1 | 40 Million CNY | 33.33% |
| 2011 Q2 | 40 Million CNY | 0.0% |
| 2011 Q3 | 39 Million CNY | -2.5% |
| 2010 Q3 | 30 Million CNY | 50.0% |
| 2010 FY | 30 Million CNY | 50.0% |
| 2010 Q4 | 30 Million CNY | 0.0% |
| 2010 Q1 | 20 Million CNY | 0.0% |
| 2010 Q2 | 20 Million CNY | 0.0% |
| 2009 FY | 20 Million CNY | 0.0% |
| 2009 Q1 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q3 | 20 Million CNY | 0.0% |
| 2009 Q4 | 20 Million CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2008 Q1 | - CNY | 0.0% |
| 2008 Q2 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2008 Q3 | - CNY | 0.0% |
| 2007 Q4 | - CNY | -100.0% |
| 2007 Q3 | 157.74 Thousand CNY | 0.0% |
| 2007 Q2 | - CNY | 0.0% |
| 2007 Q1 | - CNY | -100.0% |
| 2007 FY | - CNY | -100.0% |
| 2006 Q2 | 10.37 Million CNY | 13.65% |
| 2006 Q3 | 10.37 Million CNY | 0.0% |
| 2006 Q4 | 10.76 Million CNY | 3.84% |
| 2006 FY | 10.76 Million CNY | 18.01% |
| 2006 Q1 | 9.12 Million CNY | 0.0% |
| 2005 Q3 | - CNY | 0.0% |
| 2005 Q2 | - CNY | 0.0% |
| 2005 Q1 | - CNY | 0.0% |
| 2005 FY | 9.12 Million CNY | 0.0% |
| 2005 Q4 | 9.12 Million CNY | 0.0% |
| 2004 Q3 | - CNY | 0.0% |
| 2004 Q1 | - CNY | 0.0% |
| 2004 Q2 | - CNY | 0.0% |
| 2004 FY | - CNY | 0.0% |
| 2004 Q4 | - CNY | 0.0% |
| 2003 Q3 | - CNY | -100.0% |
| 2003 Q2 | 2.32 Million CNY | 0.0% |
| 2003 FY | - CNY | -100.0% |
| 2003 Q4 | - CNY | 0.0% |
| 2002 Q4 | 20 Million CNY | 0.0% |
| 2002 FY | 20 Million CNY | 0.0% |
| 2001 FY | - CNY | 0.0% |
| 2000 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 75.17 Million CNY | 52.855% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 305.75 Million CNY | 88.408% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 170.1 Million CNY | 79.164% |
| Aurora Optoelectronics Co.,Ltd. | 13.33 Million CNY | -165.803% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 7.23 Million CNY | -390.103% |
| NanJing Pharmaceutical Company Limited | 2.11 Billion CNY | 98.326% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 39.11 Million CNY | 9.381% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | - CNY | -Infinity% |